0001209191-19-061057.txt : 20191217
0001209191-19-061057.hdr.sgml : 20191217
20191217210949
ACCESSION NUMBER: 0001209191-19-061057
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20191213
FILED AS OF DATE: 20191217
DATE AS OF CHANGE: 20191217
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Cui Jingrong Jean
CENTRAL INDEX KEY: 0001772259
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38871
FILM NUMBER: 191291149
MAIL ADDRESS:
STREET 1: C/O TURNING POINT THERAPEUTICS, INC.
STREET 2: 10628 SCIENCE CENTER DR., STE. 225
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Turning Point Therapeutics, Inc.
CENTRAL INDEX KEY: 0001595893
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 463826166
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 10628 SCIENCE CENTER DRIVE, SUITE 200
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 858-926-5251
MAIL ADDRESS:
STREET 1: 10628 SCIENCE CENTER DRIVE, SUITE 200
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
FORMER COMPANY:
FORMER CONFORMED NAME: TP Therapeutics, Inc.
DATE OF NAME CHANGE: 20181018
FORMER COMPANY:
FORMER CONFORMED NAME: TP Therapeutics, INC
DATE OF NAME CHANGE: 20140106
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-12-13
0
0001595893
Turning Point Therapeutics, Inc.
TPTX
0001772259
Cui Jingrong Jean
C/O TURNING POINT THERAPEUTICS, INC.
10628 SCIENCE CENTER DRIVE, STE. 200
SAN DIEGO
CA
92121
1
1
0
0
Chief Scientific Officer
Common Stock
1301298
D
Common Stock
2019-12-13
4
S
0
7100
55.43
D
1019119
I
By spouse
Common Stock
2019-12-13
4
S
0
3800
56.17
D
1015319
I
By spouse
Common Stock
2019-12-13
4
S
0
600
56.95
D
1014719
I
By spouse
Common Stock
2019-12-16
4
S
0
600
55.45
D
1014119
I
By spouse
Common Stock
2019-12-16
4
S
0
2000
56.84
D
1012119
I
By spouse
Common Stock
2019-12-16
4
S
0
1300
57.59
D
1010819
I
By spouse
Common Stock
2019-12-16
4
S
0
5000
58.75
D
1005819
I
By spouse
Common Stock
2019-12-16
4
S
0
2400
59.76
D
1003419
I
By spouse
Common Stock
2019-12-16
4
S
0
200
60.43
D
1003219
I
By spouse
Common Stock
2019-12-17
4
S
0
3600
60.30
D
999619
I
By spouse
Common Stock
2019-12-17
4
S
0
8100
61.13
D
991519
I
By spouse
Common Stock
2019-12-17
4
S
0
6495
62.05
D
985024
I
By spouse
Common Stock
2019-12-17
4
S
0
305
62.71
D
984719
I
By spouse
Reported transaction occurred pursuant to Rule 10b5-1 Plan adopted by Yishan (Peter) Li.
The weighted average sale price for the transaction reported was $55.43, and the range of prices were between $54.775 and $55.77. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
The weighted average sale price for the transaction reported was $56.17, and the range of prices were between $55.825 and $56.78. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
The weighted average sale price for the transaction reported was $56.95, and the range of prices were between $56.84 and $57.04. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
The weighted average sale price for the transaction reported was $55.45, and the range of prices were between $55.05 and $55.98. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
The weighted average sale price for the transaction reported was $56.84, and the range of prices were between $56.20 and $57.19. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
The weighted average sale price for the transaction reported was $57.59, and the range of prices were between $57.22 and $57.90. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
The weighted average sale price for the transaction reported was $58.75, and the range of prices were between $58.305 and $59.265. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
The weighted average sale price for the transaction reported was $59.76, and the range of prices were between $59.41 and $60.34. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
The weighted average sale price for the transaction reported was $60.30, and the range of prices were between $59.66 and $60.60. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
The weighted average sale price for the transaction reported was $61.13, and the range of prices were between $60.68 and $61.68. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
The weighted average sale price for the transaction reported was $62.05, and the range of prices were between $61.70 and $62.70. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
The weighted average sale price for the transaction reported was $62.71, and the range of prices were between $62.71 and $62.74. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
/s/ Annette North, Attorney-in-Fact
2019-12-17